That has spread to other parts of the body or cannot be removed by surgery, and whose tumor is KRAS G12C positive, and who have received at least one prior treatment.1

LUMAKRAS™ patient and grandchild LUMAKRAS™ patient and grandchild

How LUMAKRAS®
may help

SEE HOW

Once-daily
dosing

LEARN MORE

Find financial
support

EXPLORE OPTIONS

THE FIRST ONCE-DAILY ORAL TREATMENT FOR PEOPLE LIVING
WITH KRAS G12C POSITIVE NON-SMALL CELL
LUNG CANCER (NSCLC)1

That has spread to other parts of the body or cannot be removed by surgery, and whose
tumor is KRAS G12C positive, and who have received at least one prior treatment.1

Not Chemotherapy2

References: 1. LUMAKRAS® (sotorasib) Patient Information. Thousand Oaks, CA: Amgen 2021. 2. LUMAKRAS® (sotorasib) Prescribing Information. Thousand Oaks, CA: Amgen 2021.

×
Amgen stands with our local Los Angeles community. Click here to learn what we are doing to support and contact us if the fires have impacted your access to Amgen medication.